Literature DB >> 12849930

Genetics of the serotonergic system in suicidal behavior.

Victoria Arango1, Yung-yu Huang, Mark D Underwood, J John Mann.   

Abstract

Genetic factors contribute to the risk of psychopathology in many psychiatric conditions, but the specific genes are yet to be identified. Neurotransmitter alterations are implicated in the etiology of psychopathology based, in part, on studies of neurotransmitter receptors and their biosynthetic or degradative enzymes in postmortem tissue. Identification of the altered receptors and enzymes serves to identify candidate genes of potential etiological significance. Polymorphisms in these genes can contribute to alterations in protein function in vivo that are part of the neurochemical underpinnings of psychopathologies such as major depressive disorder, psychoses, alcoholism, personality disorders, aggressive-impulsive traits, or suicidal behavior. Altered serotonergic function is implicated in the etiology and pathogenesis of several major psychiatric conditions. In particular, there is much evidence for an association of lower serotonergic function and suicidal behavior. Thus genes related to the serotonergic system are candidate genes worthy of study as part of the genetic diathesis for suicidal behavior. This review examines the following polymorphisms in the serotonin biosynthetic enzyme tryptophan hydroxylase (TPH; A779C substitution), the serotonin transporter (5-HTT, 5-HTTLPR allele), the 5-HT(1B) receptor (G861C, C129T substitution) and the 5-HT(2A) receptor (T102C) for their relationship to suicidal behavior. For the TPH gene, we found the less common U or A allele variant of the A779C polymorphism was associated with suicide attempt. Other studies have found the U allele to be associated with aggression and lower serotonergic function in vivo. A 44 base pair insertion/deletion in the 5' flanking promoter region of the 5-HTT gene may result in less 5-HTT expression and 5-HTT binding. We examined 220 cases postmortem and found no association between the promoter genotype and 5-HTT binding. We also found no association with major depressive disorder (MDD), suicide or pathological aggression, despite finding significantly fewer 5-HTT sites in the prefrontal cortex of depressed and/or suicide cases. In genomic DNA samples from 178 unrelated subjects, we detected two polymorphisms for the 5-HT(1B) receptor at nucleotides 861 and 129. However, no association between either polymorphism and depression, suicide, aggression, or alcoholism was observed. There are two common polymorphisms for the 5-HT(2A) receptor gene in humans. The results of studies of 5-HT(2A) receptor gene polymorphisms do not indicate significant major associations with suicidal behavior. In contrast, the 5-HT(2A) receptor itself is reported to be increased in suicide. Functional polymorphisms involving the promoter region that affect gene expression may explain this finding. Studies of candidate genes related to serotonergic function in brain are increasingly used to establish genetic alterations contributing to psychiatric illness. The most meaningful studies combine the study of candidate genes with direct measures of related proteins as well as psychopathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12849930     DOI: 10.1016/s0022-3956(03)00048-7

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  51 in total

1.  Genetic and environmental contributions to self-reported thoughts of self-harm and suicide.

Authors:  Robert R Althoff; James J Hudziak; Gonneke Willemsen; Vicenta Hudziak; Meike Bartels; Dorret I Boomsma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-12-07       Impact factor: 3.568

Review 2.  Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses.

Authors:  Dawei Li; Lin He
Journal:  Hum Genet       Date:  2006-02-01       Impact factor: 4.132

3.  Postmortem parietal cortex TPH2 expression is not altered in schizophrenic, unipolar-depressed, and bipolar patients vs control subjects.

Authors:  Alon Shamir; Galit Shaltiel; Itzhak Levi; R H Belmaker; Galila Agam
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population.

Authors:  X Liu; H Li; W Qin; G He; D Li; Y Shen; J Shen; N Gu; G Feng; L He
Journal:  J Med Genet       Date:  2006-02       Impact factor: 6.318

5.  Neurobiology of suicidal behavior. An integration of biological and clinical findings.

Authors:  Juan J Carballo; Chibuikem P Akamnonu; Maria A Oquendo
Journal:  Arch Suicide Res       Date:  2008

6.  Differentiating adolescent self-injury from adolescent depression: possible implications for borderline personality development.

Authors:  Sheila E Crowell; Theodore P Beauchaine; Ray C Hsiao; Christina A Vasilev; Mona Yaptangco; Marsha M Linehan; Elizabeth McCauley
Journal:  J Abnorm Child Psychol       Date:  2012-01

Review 7.  Mood disorders after TBI.

Authors:  Ricardo E Jorge; David B Arciniegas
Journal:  Psychiatr Clin North Am       Date:  2014-01-14

Review 8.  Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2.

Authors:  X Zhang; J-M Beaulieu; R R Gainetdinov; M G Caron
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

9.  Effect of tryptophan hydroxylase-2 rs7305115 SNP on suicide attempts risk in major depression.

Authors:  Yuqi Zhang; Changsong Zhang; Guozhen Yuan; Jianjun Yao; Zaohuo Cheng; Chaojun Liu; Qinghai Liu; Gairong Wan; Guizhi Shi; Yiren Cheng; Yang Ling; Ke Li
Journal:  Behav Brain Funct       Date:  2010-08-25       Impact factor: 3.759

10.  Serotonin synthesis, release and reuptake in terminals: a mathematical model.

Authors:  Janet Best; H Frederik Nijhout; Michael Reed
Journal:  Theor Biol Med Model       Date:  2010-08-19       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.